Urotensin II Evokes Potent Vasoconstriction in Humansin Vivo

British Journal of Pharmacology - United States
doi 10.1038/sj.bjp.0704448
Full Text
Abstract

Available in full text

Categories
Pharmacology
Date
Authors
Publisher

Wiley-Blackwell

Related search

Novel Potent and Efficacious Nonpeptidic Urotensin II Receptor Agonists

English

Urotensin-Ii Signaling Mechanism in Rat Coronary Artery: Role of STIM1 and Orai1-Dependent Store Operated Calcium Influx in Vasoconstriction

Arteriosclerosis, Thrombosis, and Vascular Biology
Cardiovascular MedicineCardiology
2012English

Erratum: Human Urotensin-Ii Is a Potent Vasoconstrictor and Agonist for the Orphan Receptor GPR14

Nature
Multidisciplinary
1999English

Urotensin II: An Inflammatory Cytokine

Journal of Endocrinology
EndocrinologyMetabolismDiabetes
2019English

Plasma Urotensin II Concentration in Gestational Diabetes

ARCHIVES OF CLINICAL AND EXPERIMENTAL MEDICINE
2017English

GSK1562590, a Slowly Dissociating Urotensin-Ii Receptor Antagonist, Exhibits Prolonged Pharmacodynamic Activity Ex Vivo

British Journal of Pharmacology
Pharmacology
2010English

Urotensin-Ii Contributes to Pulmonary Vasoconstriction in a Perinatal Model of Persistent Pulmonary Hypertension of the Newborn Secondary to Meconium Aspiration Syndrome

Pediatric Research
Child HealthPediatricsPerinatology
2010English

Unraveling the Active Conformation of Urotensin II.

Journal of Medicinal Chemistry
Drug DiscoveryMolecular Medicine
2004English

Protein Expression of Urotensin II, Urotensin-Related Peptide and Their Receptor in the Lungs of Patients With Lymphangioleiomyomatosis

Peptides
BiochemistryEndocrinologyPhysiologyCellularMolecular Neuroscience
2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy